Delivery Order SPE2DB22D1103-SPE2DB25FH2D2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Fexofenadine HCL 180 mg tablets in a quantity of 500 units, valued at $2,287.74. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of September 9, 2025. The award represents a child delivery order under a larger contract vehicle,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,352 units of Fexofenadine HCl 180 mg tablets. The firm-fixed-price contract has a ceiling value of $1,093.98 and will run through August 6, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fexofenadine HCL 180 mg tablets. The $1,813.85 firm-fixed-price contract has a completion date of September 26, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, to provide a wide range of pharmaceutical and medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,501.20, is for the delivery of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,533 units of Fexofenadine HCL 180 mg tablets. The $1,340.43 ceiling value contract has a completion date of September 21, 2022. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov) until June 2025, has an extensive history of providing pharmaceutical and medical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,272,960 units of Fexofenadine HCL 180 mg tablets, a medication used to treat allergies. The contract has a ceiling value of $1,216.68 and a completion date of September 25, 2023. This contract is a delivery order and is priced as a firm-fixed price. AmerisourceBergen holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,198,817 units of Fexofenadine HCL 180 mg tablets. The award, valued at $2,367.40, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp will deliver the pharmaceutical products from their facility in Conshohocken, Pennsylvania. This award is a task order issued under an...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,810,234 units of Fexofenadine HCL 180 mg tablets, with a total ceiling value of $21,068.52 and a period of performance through December 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,430.38, is for the delivery of fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of February 14, 2025 and is a firm fixed-price type. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The $1,640.52 firm fixed price contract is for the delivery of 4,558,478,347 units of Fexofenadine HCL 180 mg tablets. This order is made under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and will...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH2D2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Fexofenadine HCL 180 mg tablets (500 count) with a contract ceiling value of $1,811.12. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract was competitively awarded without a set-aside designation, and performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This comprehensive vehicle enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The delivery order for fexofenadine, a common antihistamine medication, exemplifies the company's role in providing essential pharmaceutical inventory to Defense Health Agency and other federal healthcare systems through flexible contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/11/25 |